HUP0103204A2 - Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0103204A2
HUP0103204A2 HU0103204A HUP0103204A HUP0103204A2 HU P0103204 A2 HUP0103204 A2 HU P0103204A2 HU 0103204 A HU0103204 A HU 0103204A HU P0103204 A HUP0103204 A HU P0103204A HU P0103204 A2 HUP0103204 A2 HU P0103204A2
Authority
HU
Hungary
Prior art keywords
amino
aryl
new
pyridine
ones
Prior art date
Application number
HU0103204A
Other languages
English (en)
Inventor
Thomas Arnold
Reni Bartsch
Vladimir Granik
Sofia Grizik
Hans-Joachim Lankau
Angelika Rostock
Klaus Unverferth
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of HUP0103204A2 publication Critical patent/HUP0103204A2/hu
Publication of HUP0103204A3 publication Critical patent/HUP0103204A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A tal lm ny új (1) ltal nos képletű 4-amino-1-aril-piridin-2-onszrmazékokra, elő llít sukra szolg ló elj r sra, valamintgyógyszerkénti, főleg kül"nb"ző epilepsziaform k kezelésére alkalmasgyógyszerkénti alkalmaz sukra vonatkozik. Az (1) ltal nos képletben nértéke 0, 1, 2, 3, 4 vagy 5, X jelentése hidrogénatom, C1-C4-alkil-,C1-C4-alkoxi-, trifluormetil-, trifluormetoxicsoport vagy halogénatomés A jelentése amino-, C1-C4-alkilamino-, C1-C4-dialkilamino-,morfolino-, piperidino- vagy pirrolidinocsoport. Ó
HU0103204A 1998-08-07 1999-07-28 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same, their use and pharmaceutical compositions containing them HUP0103204A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19835918A DE19835918A1 (de) 1998-08-07 1998-08-07 Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung
PCT/EP1999/005399 WO2000007988A1 (de) 1998-08-07 1999-07-28 Neue, antikonvulsiv wirkende 4-amino-1-aryl-pyridin-2-one und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
HUP0103204A2 true HUP0103204A2 (hu) 2002-04-29
HUP0103204A3 HUP0103204A3 (en) 2002-06-28

Family

ID=7876889

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103204A HUP0103204A3 (en) 1998-08-07 1999-07-28 New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same, their use and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US6071911A (hu)
EP (1) EP1102748A1 (hu)
JP (1) JP2002522420A (hu)
KR (1) KR20010074802A (hu)
CN (1) CN1322197A (hu)
AR (1) AR021186A1 (hu)
AU (1) AU5507499A (hu)
BG (1) BG105196A (hu)
BR (1) BR9912849A (hu)
CA (1) CA2279692C (hu)
DE (1) DE19835918A1 (hu)
HU (1) HUP0103204A3 (hu)
IL (1) IL141200A0 (hu)
NO (1) NO20010575L (hu)
NZ (1) NZ509914A (hu)
PL (1) PL346013A1 (hu)
RU (1) RU2001106634A (hu)
SK (1) SK2002001A3 (hu)
TR (1) TR200100370T2 (hu)
WO (1) WO2000007988A1 (hu)
ZA (1) ZA200100999B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2320973T3 (es) 2000-06-12 2009-06-01 EISAI R&D MANAGEMENT CO., LTD. Compuestos de 1,2-dihidropiridina, procedimiento para su preparacion y uso de los mismos.
GB0129260D0 (en) 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
MY148809A (en) 2004-07-06 2013-05-31 Eisai R&D Man Co Ltd Crystals of 1,2-dihydropyridine compound and their production process
KR20210107644A (ko) 2018-12-14 2021-09-01 에자이 알앤드디 매니지먼트 가부시키가이샤 1,2-디하이드로피리딘 화합물의 수성 기반 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118768A (en) * 1975-02-19 1976-10-18 Shigeo Senda Method for preparing 4-amino-2-pyridone derivatives
EP0110091B1 (de) * 1982-10-27 1987-01-21 Degussa Aktiengesellschaft 2-Amino-3-Acylamino-6-benzylamino-pyridin-Derivate mit anti-epileptischer Wirkung

Also Published As

Publication number Publication date
KR20010074802A (ko) 2001-08-09
AU5507499A (en) 2000-02-28
NO20010575L (no) 2001-04-04
JP2002522420A (ja) 2002-07-23
BR9912849A (pt) 2001-05-08
SK2002001A3 (en) 2002-01-07
CN1322197A (zh) 2001-11-14
CA2279692A1 (en) 2000-02-07
NO20010575D0 (no) 2001-02-02
AR021186A1 (es) 2002-07-03
ZA200100999B (en) 2001-12-14
HUP0103204A3 (en) 2002-06-28
TR200100370T2 (tr) 2001-08-21
DE19835918A1 (de) 2000-02-10
NZ509914A (en) 2002-11-26
PL346013A1 (en) 2002-01-14
BG105196A (en) 2001-12-29
US6071911A (en) 2000-06-06
IL141200A0 (en) 2002-02-10
EP1102748A1 (de) 2001-05-30
RU2001106634A (ru) 2004-02-27
WO2000007988A1 (de) 2000-02-17
CA2279692C (en) 2003-10-07

Similar Documents

Publication Publication Date Title
HUT36784A (en) Process for producing spasmolytic sulfanate derivatives and pharmaceutical compositions containing them as active agents
ATE212223T1 (de) Verwendung von sertraline zur herstellung eines arzneimittels zur behandlung von obsessiv- kompulsiven erkrankungen
CA2333965A1 (en) Method of enhancing lysosomal .alpha.-galactosidase a
MX9802130A (es) Agonistas adrenergicos beta3 selectivos.
ATE409486T1 (de) Behandlung hyperproliferativer erkrankungen
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE60133716D1 (de) Verwendungen eines getränks enthaltend ein polyphosphat zur behandlung von zahnerosionen
NZ259866A (en) Topical composition, ketoconazole plus a acetonide glucocorticosteroid, use of ketoconazole in compositions
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES8802014A1 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
DE69506686T2 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
RU94046141A (ru) Замещенные производные /арилалкоксибензил/ аминопропанамида, способы их получения, фармацевтическая композиция
KR910007867A (ko) 페네타놀아민 화합물
HUP0103204A2 (hu) Új, görcsoldó hatású 4-amino-1-aril-piridin-2-on-származékok, eljárás az előállításukra, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
DE69227583T2 (de) Arylmorpholine, herstellung und verwendung
HUP0004336A2 (hu) Készítmény alkoholistákban fellépő megvonási tünetek és alkohol iránti ellenállhatatlan szükségérzet elnyomására és az alkohol túlzott mértékű fogyasztásának megelőzésére egészséges alanyokban
PL320342A1 (en) Thrombin inhibitor containing infusion solution, stable during storage
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
HU9204171D0 (en) Method for producing aralkyl esters of 4,5-dihydroxi-9,10-dihydro-9,10-dioxo-2-anthracene-carboxylic acid as well as medical preparatives containing them
HUT45250A (en) Process for producing 5-substituted octahydro-indolysin derivatives and pharmaceutical compositions containing them as active components
RU94044457A (ru) Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин
JPS643185A (en) Active compound, its production and pharmaceutical composition containing same
WO1995000154B1 (en) Antidepressant agents with a rapid onset of action